THE LIFE IS IN THE BREATH

What this means for you

This application is over — abandoned 29 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98564323

Mark type

Stylized text

Filed

22 May 2024

Abandoned

29 Aug 2025

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of COPD, chronic bronchitis, mucus hypersecretion, emphysema, asthma, sleep apnea, pulmonary hypertension, idiopathic pulmonary fibrosis (IPF), and other diseases, disorders, and conditions affecting the lungs and airways; Pharmaceutical preparations for the treatment of COPD, chronic bronchitis, mucus hypersecretion, emphysema, asthma, sleep apnea, pulmonary hypertension, idiopathic pulmonary fibrosis (IPF), and other diseases, disorders, and conditions affecting the lungs and airways; Pharmaceutical preparations for treating asthma; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
• Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

Owner

• Rejuve Therapeutics, Inc., Houston, TX, US

Prosecution history

• 30 Oct 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 30 Oct 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 28 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 28 May 2025 — NON-FINAL ACTION E-MAILED
• 28 May 2025 — NON-FINAL ACTION WRITTEN
• 22 May 2025 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
• 20 May 2025 — WITHDRAWN FROM PUB - OG REVIEW QUERY
• 25 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 25 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
• 25 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 25 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
• 25 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN
• 01 Apr 2025 — ASSIGNED TO EXAMINER
• 07 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 07 Dec 2024 — NON-FINAL ACTION E-MAILED